TMX Newsfile News Releases (InvestorIdeas) [cannabis]

Entheon Announces Continuance into British Columbia

Thu, 08 Oct 2026 18:49:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - October 8, 2026) - Entheon Biomedical Corp. (CSE: ENBI.X) (OTCID: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has continued out of the jurisdiction of Canada under the Canada Business Corporations Act into the provincial jurisdiction of British Columbia under the Business Corporations Act (British Columbia) (the "BCBCA"). Shareholders approved the continuance at the Company's annual general and special meeting of...

Psyched Wellness Announces Secured Term Loan

Thu, 08 Oct 2026 17:15:00 -0400

Toronto, Ontario--(Newsfile Corp. - October 8, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCID: PSYCF) (FSE: 5U9) (the "Company" or "Psyched Wellness"), a life sciences company focused on the production and distribution of Amanita Muscaria-derived health and wellness products, announces that it has entered into secured term notes (the "Notes") with Gotham Green Fund I, L.P. and Gotham Green Fund I (Q), L.P. (together the "Lenders") for an aggregate principal amount of US$110,577 (the "Loan")....

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Licence Agreement with the University of California, San Francisco for a Phase 2 Trial of Psilocybin in Methamphetamine Use Disorder Among People with HIV

Thu, 08 Oct 2026 08:19:00 -0400

Filament will supply PEX010 to a University of California, San Francisco trial testing whether a single dose of psilocybin can be used to help people living with HIV reduce methamphetamine use, a condition with no approved medication.Toronto, Ontario--(Newsfile Corp. - October 8, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its...

Captiva Verde to Install and Build First Water Stations for the Ritz-Carlton, Amelia Island

Thu, 01 Oct 2026 09:00:00 -0400

Jacksonville, Florida--(Newsfile Corp. - October 1, 2026) - Captiva Verde Corp. (CSE: PWR) (OTC Pink: CPIVF) (the "Company or Captiva") announces an agreement to launch the first atmospheric water ("AWG") stations for The Ritz-Carlton, Amelia Island. The terms of the agreement are confidential. The operational effective date is scheduled for October 26 or earlier.The Ritz-Carlton Hotel Company is a wholly-owned subsidiary of Marriott International with approximately 10,000 properties in 146...

CannabCo's Odourless Cannabis Goes From Headline-Making Innovation to More Than 300 Ontario Retail Locations

Thu, 01 Oct 2026 08:36:00 -0400

Toronto, Ontario--(Newsfile Corp. - October 1, 2026) - CannabCo Pharmaceutical Corp. ("CannabCo" or the "Company") announced today that its Odourless OG product is now stocked, ordered or being onboarded by more than 300 licensed Ontario cannabis retailers, only months after its Ontario launch.What began as a headline-making Canadian cannabis innovation is becoming a commercial reality through retailer adoption, product education and word of mouth.The milestone marks a significant transition for...

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to the University of Calgary for Phase 2 Trial of Psilocybin-Assisted Therapy for PTSD in Survivors of Intimate Partner Violence

Tue, 29 Sep 2026 07:53:00 -0400

Filament has shipped PEX010 to the University of Calgary for PsiPTSD, a Phase 2 trial of psilocybin-assisted therapy for post-traumatic stress disorder in survivors of intimate partner violence.Toronto, Ontario--(Newsfile Corp. - September 29, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic sector. Through its wholly owned subsidiary Filament Health...

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Expands Supply Agreement with the University of Chieti-Pescara for PEX010 in the TEMPO Clinical Trial of Psilocybin for Treatment-Resistant Depression in Italy

Fri, 25 Sep 2026 08:48:00 -0400

Following authorization of the TEMPO trial under the European Union Clinical Trials Regulation, Filament has expanded its supply agreement with the University G. d'Annunzio of Chieti-Pescara to support an increase in the number of trial participants.Toronto, Ontario--(Newsfile Corp. - September 25, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic...

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Issued New Canadian Patent, Extending the Broadest Natural Psilocybin Patent Estate

Tue, 22 Sep 2026 07:33:00 -0400

A new Canadian patent, "Psychoactive Alkaloid Extraction and Composition with Controlled Dephosphorylation," has been issued by the Canadian Intellectual Property Office, adding to the intellectual property estate behind PEX010, the standardized natural psilocybin drug candidate supporting and supplying more than 80 studies worldwide.Toronto, Ontario--(Newsfile Corp. - September 22, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an...

Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Delivers PEX010 to Bruyere Health Research Institute's Phase 3 Trial of Microdose Psilocybin in Palliative Care

Mon, 21 Sep 2026 07:49:00 -0400

Filament has shipped PEX010 to Bruyère Health Research Institute for its Phase 3 placebo-controlled trial, which follows a published Phase I/II study that found microdose psilocybin safe, feasible and potentially effective for psychological distress in people with advanced illness.Toronto, Ontario--(Newsfile Corp. - September 21, 2026) - Rhelion Life Sciences Corp. (CSE: RHEL) (FSE: 4YX) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research...

Simply Solventless Outlines Path to Planned CCAA Exit, Announces Approval of $1.0 Million in Rebates, Settlement of Vendor Take-Back Debt, Revocation of Management Cease Trade Order, and Extension of Stay of CCAA Proceedings, & Provides Financing Update

Mon, 21 Sep 2026 07:05:00 -0400

Calgary, Alberta--(Newsfile Corp. - September 21, 2026) - Simply Solventless Concentrates Ltd. (TSXV: HASH) ("SSC") is pleased to announce a series of milestones and events that collectively chart the path towards exiting its previously announced restructuring ("Restructuring") between October 31, 2026, and November 30, 2026. These milestones and events include the approval (and pending receipt) of $1.0 million of government rebates ("Rebates"), the settlement of $0.6 million of vendor take-back...